PSMD11 Inhibitors

The chemical class referred to as PSMD11 Inhibitors consists of compounds that inhibit the proteasome, a complex protein degradation machine in which PSMD11 plays a crucial regulatory role. The proteasome is responsible for degrading ubiquitinated proteins, thus regulating various cellular processes including cell cycle, apoptosis, and DNA repair. Inhibition of the proteasome can indirectly affect the function of PSMD11 by disrupting its ability to regulate protein degradation.

Inhibitors in this class, such as peptide aldehydes (like MG-132), boronic acid derivatives (like Bortezomib, Ixazomib, and Delanzomib), epoxyketones (like Carfilzomib and Oprozomib), β-lactones (like Marizomib, Lactacystin, and Salinosporamide A), and steroidal lactones (like Withaferin A), bind to and inhibit the activity of the proteasome's catalytic sites. This binding prevents the proteasome from performing its function of degrading proteins. As a result, the normal function of PSMD11 in recognizing and unfolding ubiquitinated proteins is compromised, as the proteins cannot be translocated into the 20S core particle for degradation. The inhibitors are varied in structure and origin, with some being synthetic, like the boronic acid derivatives, and others being natural products, like Epoxomicin and Salinosporamide A. They share the common feature of interacting with the proteasome's active sites, leading to an accumulation of ubiquitinated proteins and a subsequent cascade of effects within the cell due to the interruption of protein turnover. These inhibitors have been crucial in studying the proteasome's role in cells and the specific functions of its regulatory components, including PSMD11